Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students on Their Papillomavirus Vaccination Coverage.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Teenagers
- Sponsor
- Hopital Foch
- Enrollment
- 1170
- Primary Endpoint
- Impact Assessement of a sexual health talk with middle school students in 3rd grade on the dispensation of HPV vaccines among young people born in 2010.
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
This is a prospective pragmatic study to assess the impact of a HPV vaccination talk in secondary school on actual vaccine dispensing in test communes compared with control communes. The talk consist on a briefing on the importance of vaccination.
This is a controlled study, since two communes will benefit from the HPV vaccination talk, while the other two will serve as controls without set up of the HPV vaccination talk. The set up of this presentation will be open-label.
Detailed Description
The main aim of the present study is to investigate the impact of HPV vaccination talk with 3rd grade school children on HPV vaccine dispensing by making them actors in their own health. A significant benefit on vaccination coverage is expected. In addition, a flyer providing information and raising awareness of infections and the benefits of HPV vaccination will be sent to parents at the end of the talk.
Investigators
Eligibility Criteria
Inclusion Criteria
- •3rd grade students enrolled in public secondary schools in Suresnes and Rueil-Malmaison.
Exclusion Criteria
- •Students absent on the day of the talk.
- •Students unwilling/unable to complete questionnaire.
Outcomes
Primary Outcomes
Impact Assessement of a sexual health talk with middle school students in 3rd grade on the dispensation of HPV vaccines among young people born in 2010.
Time Frame: 12 months preceding the talk and the 6 months following the talk
The aim of this study is to evaluate the impact of a sexual health talk with middle school students in 3rd grade on the dispensation of HPV vaccines among young people born in 2010. The main evaluation criterion for this study is the number of monthly HPV vaccine dispensations among young people born between 01/01/2010 and 31/12/2010. These data will be communicated by the OSPHARM cooperative or by pharmacies, over the 12 months preceding the talk and the 6 months following, in order to be able to assess the impact of the latter on dispensations.
Secondary Outcomes
- 1rst Secondary outcoume(8 weeks)
- 2nd Secondary outcoume(8 weeks)
- 3rd secondary outcoume(8 weeks)
- 4 th secondary outcoume(8 weeks)
- 5 th secondary outcoume(6 months after talk)